Tell Your Story
”I was diagnosed two years ago with non-Hodgkin's lymphoma. Boy, does news like that ever change your life and your outlook on what is really important!I have now been in remission for almost two years, and I'm thrilled to say that two months ago I gave birth to a beautiful baby girl named Grace. I also am happy to say that only 10 months after completing chemo I walked all 60 miles of the Breast Cancer 3-Day Walk.” Mary, age 42
When we are faced with a personal difficulty, it can be encouraging to learn how someone else has coped. The more like us they are, the better we feel. That’s why the Leukemia & Lymphoma Society created Life Mosaic, an online collection of personal stories of hope.
The Life Mosaic stories and images have been submitted by patients, families and friends whose lives have been touched by leukemia, lymphoma, Hodgkin's disease, myeloma and other blood-related cancers. The Life Mosaic is an opportunity to share your personal cancer journey and to experience the challenges and triumphs of others living with cancer. You may search for specific stories of interest within the Life Mosaic by disease, age, name and geography. To read more, go to:
http://www.llslifemosaic.com
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
